Skip to main content
OpenTrials
Completed

NCT Number: NCT06503926

Impact of COVID-19 Vaccination on Balance Function Among Adolescents: A Long-Term Perspective

Long term impact of COVID 19 vaccination on dizziness-related disability and balance in adolescence

Completed

Looking for future studies?

Notify Me

Key information

Conditions

SARS CoV 2 Vaccination

Age range

10 year–17 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Sinai University

Ismailia, Ismailia Governorate, 11749, Egypt

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adolescence age range 10-17
  • received a dose or more of an approved COVID-19 vaccine at least one year before the study enrollment.

the ability to complete all assessment measures independently.

Exclusion criteria

  • vestibular or neurological disorders diagnosed before vaccination.
  • mixed COVID-19 vaccine types.
  • a history of traumatic brain injury.
  • current use of medications that affect balance.
  • documented COVID-19 infection within three months of assessment.
  • physical limitations that prevented them from completing balance testing.

Treatment and study plan

SARS-COV-2 vaccination

Other

Vaccination

Primary outcomes

  1. Impact on Balance

    Time frame: Through study completion, an average of 1 day - 1 year after taking the vaccine

    The pediatric balance scale is used to assess balance (Lowest score =0 " worst"- Maximum score is 56 " Perfect Balance"

  2. Functional Disability

    Time frame: Through study completion, an average of 1 day - 1 year after taking the vaccine

    The Dizziness Handicap Inventory is used to assess functional disability related to dizziness

Secondary outcomes

  1. Emotional Disability

    Time frame: Through study completion, an average of 1 day - 1 year after taking the vaccine

    The Dizziness Handicap Inventory is used to assess emotional disability related to dizziness

  2. Physical Disability

    Time frame: Through study completion, an average of 1 day - 1 year after taking the vaccine

    The Dizziness Handicap Inventory is used to assess physical disability related to dizziness

Sponsors and collaborators

Lead sponsor

Sinai University

Other

Registry information

Important dates

Study start
2023
Primary completion
2024
Study completion
2024
First posted
Jul 16, 2024
Registry last updated
Jul 16, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.